SEC Form 4 research
| Issuer | Dermata Therapeutics, Inc. |
|---|---|
| Tickers | DRMA |
| Reporting owners | 13 |
| Officers and directors | 3 |
| Last public filing | 2026-08-19 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-18 | 2026-08-16 | PROEHL GERALD T | A | 170,068 | Not reported | Not reported |
| 2026-08-18 | 2026-08-16 | PROEHL GERALD T | A | 1,360,544 | Not reported | Not reported |
| 2026-08-18 | 2026-08-16 | PROEHL GERALD T | A | 170,068 | Not reported | Not reported |
| 2026-08-18 | 2026-08-16 | PROEHL GERALD T | A | 170,068 | Not reported | Not reported |
| 2026-08-18 | 2026-08-16 | PROEHL GERALD T | A | 1,360,544 | Not reported | Not reported |
| 2026-08-18 | 2026-08-16 | PROEHL GERALD T | A | 1,360,544 | Not reported | Not reported |
| 2026-08-18 | 2026-08-16 | Van Hoose Kyri K. | A | 102,040 | Not reported | Not reported |
| 2026-08-18 | 2026-08-16 | Van Hoose Kyri K. | A | 102,040 | Not reported | Not reported |
| 2026-08-18 | 2026-08-16 | Van Hoose Kyri K. | A | 102,040 | Not reported | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.